Cognitive Behavioral Therapy for Adolescents With Bulimia

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
New York State Psychiatric Institute
ClinicalTrials.gov Identifier:
NCT00755391
First received: September 18, 2008
Last updated: October 25, 2012
Last verified: October 2012
  Purpose

This pilot study will evaluate the effectiveness of individual cognitive behavioral therapy (CBT) and supportive psychotherapy (SP) in reducing bulimic symptoms among adolescents.


Condition Intervention
Bulimia Nervosa
Behavioral: cognitive behavior therapy
Behavioral: Supportive Psychotherapy

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Cognitive Behavioral Therapy for Adolescents With Bulimia

Resource links provided by NLM:


Further study details as provided by New York State Psychiatric Institute:

Primary Outcome Measures:
  • Eating Disorder Examination scores [ Time Frame: 28 days ] [ Designated as safety issue: No ]

Enrollment: 8
Study Start Date: February 2008
Study Completion Date: February 2010
Primary Completion Date: February 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Placebo Comparator: supportive psychotherapy
supportive psychotherapy: 14 sessions
Behavioral: Supportive Psychotherapy
The supportive psychotherapy treatment used in this study will involve identifying issues underlying your child's eating disorder and giving your child information about the psychological processes that tend to maintain or continue eating disorder symptoms.
Active Comparator: cognitive behavior therapy
cognitive behavior therapy: 14 sessions
Behavioral: cognitive behavior therapy
The cognitive behavioral therapy used in this study will focus on developing patterns of regular eating, addressing body image issues, and ways to cope with situations that trigger eating disordered behaviors.

Detailed Description:

Patients will be randomized to have an equal chance of either receiving CBT or SP. Participants will include both individuals with DSM-IV bulimia nervosa (BN), and patients with sub-threshold BN. Adolescent patients will be treated at the New York State Psychiatric Institute, with a target recruitment of 20 patients completing the study. Participants in both conditions will be assessed prior to treatment and at the end of treatment. This trial is intended to serve as a pilot investigation to determine the feasibility and utility of a larger controlled study in this population.

  Eligibility

Ages Eligible for Study:   12 Years to 18 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Age between 12 and 18
  2. DSM-IV diagnosis of bulimia nervosa or sub-threshold bulimia nervosa (binge eating and/or purging at least once per week)

Exclusion Criteria:

  1. Diagnosis of bipolar disorder
  2. Current psychosis
  3. Drug or alcohol abuse in the past 3 months
  4. Acute Suicidal Risk
  5. Major depression producing significant functional impairment
  6. Significant medical illness
  7. Weight outside of normal weight range (between 85% and 120% of the 50th percentile for age as measured by standard growth charts)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00755391

Locations
United States, New York
New York State Psychiatric Institute
New York, New York, United States, 10032
Sponsors and Collaborators
New York State Psychiatric Institute
Investigators
Principal Investigator: Robyn Sysko, PhD New York State Psychiatric Institute
  More Information

No publications provided

Responsible Party: New York State Psychiatric Institute
ClinicalTrials.gov Identifier: NCT00755391     History of Changes
Other Study ID Numbers: 4819
Study First Received: September 18, 2008
Last Updated: October 25, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by New York State Psychiatric Institute:
BN and subthreshold BN

Additional relevant MeSH terms:
Bulimia
Bulimia Nervosa
Hyperphagia
Signs and Symptoms, Digestive
Signs and Symptoms
Eating Disorders
Mental Disorders

ClinicalTrials.gov processed this record on October 19, 2014